Maa: Australia
Kieli: englanti
Lähde: Department of Health (Therapeutic Goods Administration)
Urea(13C); 13C-Urea or Urea [13C]
DIABACT UBT 50MG TABLET PRODUCT LEAFLET (CONSUMER MEDICINE) INFORMATION Page 1 of 4 AUS PACKAGE LEAFLET: DIABACT UBT 50MG TABLETS 13 C-UREA INFORMATION FOR THE USER READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. - If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: 1. What Diabact UBT is and what it is used for 2. Before you take Diabact UBT 3. How to take Diabact UBT 4. Possible side effects 5. How to store Diabact UBT 6. Further information 1. WHAT DIABACT UBT IS AND WHAT IT IS USED FOR This medicine is for diagnostic use only to determine the presence of _Helicobacter pylori_. Diabact UBT is a breath test that can be used to determine whether or not you have a primary or remaining infection in the stomach caused by the bacterium _Helicobacter pylori._ _2. _ BEFORE YOU TAKE DIABACT UBT_ _ DO NOT TAKE DIABACT UBT - if you are allergic (hypersensitive) to 13 C-urea or to any of the other ingredients of Diabact UBT. - if you have an infection in the stomach, as it may cause a false result. USING OTHER MEDICINES Diabact UBT may be affected by other medicines. Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription._ _ - The risk for obtaining wrong diagnosis is increased if the test is performed within four (4) weeks after using antibiotics and within two (2) weeks after the last dose of acid reduction treatments. DIABACT UBT 50MG TABLET PRODUCT LEAFLET (CONSUMER MEDI Lue koko asiakirja
DIABACT UBT 50MG TABLET AUSTRALIAN PRODUCT INFORMATION Page 1 of 6 DIABACT UBT AUSTRALIAN PRODUCT INFORMATION NAME OF THE DRUG Each tablet contains Urea [ 13 C] 50mg. Structural Formula: O | | H 2 N - 13 C - NH 2 The structural formula of the 13 C-urea is identical to that of urea. The superscript ( 13 ) on the left of the chemical symbol for carbon (C) indicates the enrichment of the molecule with carbon- 13. The CAS Registry Number for 97% 13 C-enriched urea is [58069-82-2]. There is no specific CAS Registry Number for 13 C-urea enriched to not less than 99% with carbon-13. DESCRIPTION Urea [ 13 C] is urea enriched with 13 C –stable non-radioactive isotope. The chemical properties of 13 C-urea do not differ from those of natural urea, which contains the 13 C isotope at a concentration of approximately 1%. It is very soluble in water, soluble in ethanol and practically insoluble in dichloromethane. Its molecular weight is 61.05. Diabact UBT 50mg is presented as a diagnostic kit (1 tablet) or a tablet pack (10 tablets), the components of which are detailed in the PRESENTATION section of this document. For excipients, see the PRESENTATION section of this document. PHARMACOLOGY PHARMACODYNAMIC PROPERTIES Pharmacotherapeutic group: Other diagnostic agents. ATC-code: V04C X After oral ingestion 13 C-urea labeled urea tablets will rapidly disintegrate on reaching the stomach. In case of infection with _Helicobacter pylori_ (_H. pylori_) 13 C-urea is metabolized by the enzyme urease, which is present in _H. pylori_: Enzyme urease H 2 N( 13 CO)NH 2 + H 2 O 2NH 3 + 13 CO 2 The carbon dioxide, which is liberated, diffuses into the blood vessels and is transported as bicarbonate to the lungs where it is then released as 13 CO 2 in exhaled air. In the presence of bact Lue koko asiakirja